Q-omics provides the consensus-scored MTCYBP5 profile across patient tissues and cancer cell-line models. MTCYBP5 expression is associated with patient survival in 13 of 34 cancer types, with the highest sampling consensus in HNSC. Additionally, MTCYBP5 RNA expression shows 7,289 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight HNSC, and TGCT as cancer lineages where MTCYBP5 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.